All articles tagged with #psilocybin
A study using engineered viruses in mice suggests that psilocybin may help break depressive cycles by rewiring brain connections, particularly reducing negative feedback loops associated with rumination, which could explain its positive effects in treating depression. The findings highlight potential for combining psychedelics with neuromodulation techniques for targeted mental health therapies.
A review indicates that psychedelics, especially psilocybin, show promise for treating OCD, while cannabis does not, due to differences in how they interact with the brain. Clinical trials with psilocybin have shown positive results, but research faces legal and methodological challenges.
A single dose of psilocybin in mice rapidly reversed chronic pain and depression-like symptoms within 24 hours, with effects lasting at least 12 days, by calming overactive neurons in the brain's anterior cingulate cortex and requiring partial activation of serotonin receptors, highlighting potential for new treatments in humans.
A new study reveals that different mushroom species independently evolved the ability to produce the same psychoactive compound, psilocybin, through distinct enzymatic pathways, highlighting a rare case of convergent evolution in fungi with implications for medical research.
A UC Davis study found that psilocybin worsens anxiety and depression symptoms in postpartum mice and can negatively affect their offspring, suggesting that psychedelics may pose risks during the postpartum period and are not universally beneficial for mental health treatment.
New research from UC Davis indicates that psilocybin worsens postpartum depression symptoms in mice and can cause long-term anxiety and depression-like behaviors in their offspring, highlighting potential risks of psychedelic use during the postpartum period due to hormonal and developmental factors.
Researchers have discovered that two unrelated groups of mushrooms independently evolved the ability to produce the psychedelic compound psilocybin through different biochemical pathways, highlighting convergent evolution. The purpose of psilocybin in fungi remains unknown, but it may serve as a defense mechanism. This discovery expands biotechnological tools for producing psilocybin, which is being studied as a potential antidepressant, and prompts further investigation into its evolutionary role.
A five-year follow-up study shows that most individuals treated with psilocybin-assisted therapy for major depressive disorder remain in remission, suggesting lasting benefits and potential as a durable treatment option, though further research is needed.
Robin Wright discusses her experiences with psilocybin, her family life including her relationship with Sean Penn and her children, her career shifts from acting to directing, and her recent move to the UK where she is enjoying a relaxed life with her new partner, Henry Smith, while working on the series The Girlfriend.
A clinical trial found that a single dose of psilocybin combined with psychotherapy provided lasting relief from depression and anxiety in cancer patients, with significant improvements observed up to two years post-treatment, suggesting potential as a paradigm-changing mental health therapy.
A groundbreaking study found that psilocybin not only extends lifespan in aging mice but also delays cellular aging in human cells, suggesting its potential as a treatment for age-related diseases and healthy aging. The research demonstrated increased survival rates, improved physical health, and cellular markers of reduced aging, though further studies are needed to confirm safety and efficacy in humans.
A new study suggests that psilocybin, a compound found in psychedelic mushrooms, can significantly extend the lifespan of human cells by over 50% and increase survival rates in mice, indicating potential benefits for healthier aging, though further research is needed to optimize treatment protocols.
Research shows that psilocybin, the active compound in psychedelic mushrooms, can significantly reduce cellular aging and extend lifespan in mice, with potential implications for human health and aging processes, by activating pathways related to cellular senescence and telomere preservation.
Research from Emory University shows that psilocybin, the active compound in psychedelic mushrooms, can extend cellular lifespan and improve health markers in mice, suggesting potential for anti-aging therapies in humans, though further studies are needed.
Emory University researchers discovered that psilocin, derived from psychedelic mushrooms, significantly extends the lifespan of human cells and aged mice, improves health markers, and may offer a new approach to anti-aging therapies, with potential benefits for healthier aging and quality of life.